Caribou Biosciences (CRBU) Other Operating Expenses (2025)

Caribou Biosciences' (CRBU) quarterly Other Operating Expenses came in at $12.1 million in Q2 2025.

Caribou Biosciences (CRBU) Other Operating Expenses (2025) Analysis & Trends

Caribou Biosciences (CRBU) has 1 years of Other Operating Expenses data on file, last reported at $12.1 million in Q2 2025.

On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $12.1 million in Q2 2025; TTM through Mar 2026 was $12.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $12.1 million, changed N/A from the prior year.
Other Operating Expenses for Q2 2025 stood at $12.1 million.
Over the last five years, Other Operating Expenses for CRBU reached as high as $12.1 million in Q2 2025 and fell as low as $12.1 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Caribou Biosciences	156.25 Mn	38.63 Mn	-

Download Data

Date	Value
Jun 30, 2025	12.15 Mn